Results 141 to 150 of about 15,149,153 (302)

Smoking and tobacco use.

open access: yes
This page refers to tobacco products that are made and sold by tobacco ...

core  

Tobacco Chewing, Smoking and Health Knowledge: Evidence from Bangladesh [PDF]

open access: yes
Unlike the substance abuse studies in developed countries, tobacco consumption and its adverse effects in developing countries are poorly studied.
Mohammad Yunus, Shiferaw Gurmu
core  

Grandparent Prenatal Tobacco, Alcohol, Coffee, and Tea Consumption and Autism in the Third Generation

open access: yesAutism Research, EarlyView.
ABSTRACT Exogenous prenatal exposures may affect neurodevelopment across multiple generations. We investigated grandmother and grandfather smoking, alcohol, coffee, and tea consumption during pregnancy in relation to their grandchildren's risk of autism spectrum disorder (ASD).
Michelle Pearl   +6 more
wiley   +1 more source

Remote Screening for Age‐Related Olfactory Dysfunction Using the 4‐Item Concise Aging Adults Smell Test

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Zachary M. Soler   +3 more
wiley   +1 more source

Synergistic Enhancement of Antioxidant Activity in Arbutus unedo Leaf Extract by Biological Fluids: Implications for Functional and Nutraceutical Applications

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT This study examined the effect of biological fluids (saliva, blood plasma, and urine) on the antioxidant capacity of an aqueous extract derived from Arbutus unedo leaves. The extract displayed a concentration‐dependent reducing activity in the ferric reducing power assay (IC50 = 292 ± 7.54 µg/mL) and phosphomolybdenum assays (IC50 = 461.67 ± 4.
Idir Moualek   +6 more
wiley   +1 more source

Tobacco use and dementia

open access: yes, 2014
4 p.This WHO Tobacco Knowledge Summary reviews the evidence linking tobacco use and exposure to second-hand smoke with dementia, highlighting tobacco as a modifiable risk factor for reducing the occurrence and burden of the disease.
World Health Organization
core  

Exploring new avenues: Psychedelic‐assisted therapy for young people

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou   +3 more
wiley   +1 more source

Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy